首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats
【24h】

Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats

机译:Hypoxis hemercallidea显着降低高血糖和血液血糖诱导的链脲佐菌素诱导的糖尿病雄性Wistar大鼠肝肾组织中的高血糖和血压血糖诱导的氧化胁迫

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Hypoxis hemerocallidea is a native plant that grows in the Southern African regions and is well known for its beneficial medicinal effects in the treatment of diabetes, cancer, and high blood pressure. Aim. This study evaluated the effects of Hypoxis hemerocallidea on oxidative stress biomarkers, hepatic injury, and other selected biomarkers in the liver and kidneys of healthy nondiabetic and streptozotocin-(STZ-) induced diabetic male Wistar rats. Materials and Methods. Rats were injected intraperitoneally with 50mg/kg of STZ to induce diabetes. The plant extract-Hypoxis hemerocallidea (200mg/kg or 800mg/kg) aqueous solutionwas administered (daily) orally for 6 weeks. Antioxidant activities were analysed using a Multiskan Spectrumplate reader while other serum biomarkers were measured using the RANDOX chemistry analyser. Results. Both dosages (200mg/kg and 800 mg/kg) of Hypoxis hemerocallidea significantly reduced the blood glucose levels in STZ-induced diabetic groups. Activities of liver enzymes were increased in the diabetic control and in the diabetic group treated with 800mg/kg, whereas the 200mg/kg dosage ameliorated hepatic injury. In the hepatic tissue, the oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP), catalase, and total glutathione were reduced in the diabetic control group. However treatment with both doses improved the antioxidant status. The FRAP and the catalase activities in the kidney were elevated in the STZ-induced diabetic group treated with 800mg/kg of the extract possibly due to compensatory responses. Conclusion. Hypoxis hemerocallidea demonstrated antihyperglycemic and antioxidant effects especially in the liver tissue.
机译:背景。 Hypoxis hemercallidea是在南部非洲地区生长的原生植物,并且在治疗糖尿病,癌症和高血压方面,众所周知。目的。本研究评估了冬尾血均血管基因对氧化应激生物标志物,肝损伤和其他选定生物标志物的影响,健康的非糖尿病和链脲佐菌素 - (StZ-)诱导糖尿病雄性Wistar大鼠肝脏和肾脏中的其他选定生物标志物。材料和方法。用50mg / kg STZ腹膜内注射大鼠以诱导糖尿病。植物提取物 - 低氧溶血血均(200mg / kg或800mg / kg)水溶液(每日)口服施用6周。使用MultiSkan Spectrumplate Reader分析抗氧化活性,而使用RANDOX化学分析仪测量其他血清生物标志物。结果。剂量(200mg / kg和800mg / kg)的缺氧血均血症是显着降低了STZ诱导的糖尿病组的血糖水平。糖尿病对照中肝脏酶的活性和用800mg / kg处理的糖尿病组增加,而200mg / kg剂量改善肝损伤。在肝脏组织中,糖尿病对照组中,氧自由基吸收能力(ORAC),还原抗氧化能力(FRAP),过氧化氢酶和总谷胱甘肽。然而,用两种剂量治疗改善了抗氧化剂状态。肾脏中的FRAP和过氧化氢酶活性在STZ诱导的糖尿病患者中升高,可能由于补偿反应,含有800mg / kg的提取物处理。结论。 Hypoxis Hemercallidea尤其在肝组织中表现出抗血糖和抗氧化作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号